D.E. Shaw & Co’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.95M Buy
252,034
+154,211
+158% +$1.13M ﹤0.01% 2938
2025
Q4
$600K Buy
97,823
+37,610
+62% +$406K ﹤0.01% 3844
2025
Q3
$1.11M Buy
60,213
+49,776
+477% +$800K ﹤0.01% 3395
2025
Q2
$136K Buy
+10,437
New +$123K ﹤0.01% 4093
2024
Q2
Sell
-10,355
Closed -$350K 4472
2024
Q1
$350K Sell
10,355
-63,440
-86% -$2.25M ﹤0.01% 3661
2023
Q4
$2.33M Buy
73,795
+29,166
+65% +$693K ﹤0.01% 2548
2023
Q3
$1.14M Sell
44,629
-57,458
-56% -$1.77M ﹤0.01% 2984
2023
Q2
$2.93M Buy
+102,087
New +$2.78M ﹤0.01% 2315
2022
Q1
Sell
-128,363
Closed -$4.75M 5503
2021
Q4
$4.75M Buy
128,363
+32,597
+34% +$1.33M ﹤0.01% 2427
2021
Q3
$4.58M Sell
95,766
-209,324
-69% -$9.38M ﹤0.01% 2189
2021
Q2
$10.3M Buy
305,090
+225,152
+282% +$7.62M 0.01% 1473
2021
Q1
$3.3M Buy
+79,938
New +$4.77M ﹤0.01% 2162
2020
Q3
Sell
-5,874
Closed -$275K 3810
2020
Q2
$275K Buy
+5,874
New +$202K ﹤0.01% 3658
2017
Q2
Sell
-19,745
Closed -$158K 3352
2017
Q1
$158K Buy
19,745
+11,993
+155% +$111K ﹤0.01% 3156
2016
Q4
$114K Buy
7,752
+3,098
+67% +$46.3K ﹤0.01% 3335
2016
Q3
$80K Sell
4,654
-13,519
-74% -$437K ﹤0.01% 3299
2016
Q2
$571K Buy
18,173
+946
+5% +$29.8K ﹤0.01% 2732
2016
Q1
$457K Buy
17,227
+2,931
+21% +$99.2K ﹤0.01% 2827
2015
Q4
$628K Buy
14,296
+9,935
+228% +$447K ﹤0.01% 2939
2015
Q3
$184K Buy
4,361
+2,710
+164% +$143K ﹤0.01% 3513
2015
Q2
$76K Sell
1,651
-5,520
-77% -$253K ﹤0.01% 3668
2015
Q1
$283K Buy
7,171
+1,150
+19% +$50.6K ﹤0.01% 3326
2014
Q4
$157K Buy
+6,021
New +$191K ﹤0.01% 3851

Other funds holding ARCT